Foghorn Therapeutics Inc.
NASDAQ:FHTX · NASDAQ Global Market
+$0.10 today
Vol 0.18M · Avg 0.15M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-15.13%
Period High
$6.68
Period Low
$3.53
Latest
$4.15
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$387.23M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$348.49M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.79M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$265.96M
Zura Bio Limited
NASDAQ:ZURA
$240.26M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$217.19M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$212.75M
Immuneering Corporation
NASDAQ:IMRX
$157.69M
Humacyte, Inc.
NASDAQ:HUMA
$156.53M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.66M
What is the latest FHTX filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does FHTX have?
Intrinsic Alpha currently shows 20 recent filings for FHTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.